Farms.com Home   News

ISU Extension and Outreach Dairy Team webinar on December 19 Explains Extra-Label Drug Use in Cattle and How Aspirin Fits In

The Iowa State University Extension and Outreach Dairy Team monthly webinar series continues Thursday, Dec. 19, from 12 noon to 1 p.m. Allison Vander Plaats will discuss the topic of extra-label drug use.

Aspirin has never gone through the process of being approved by the Food and Drug Administration (FDA) for use in cattle. However, FDA considered aspirin to be of “low regulatory concern,” so its use in scenarios where a veterinarian determined there to be no other option for treatment was acceptable. The agency has now reversed that stance and released a letter to veterinarians this week emphasizing that aspirin use in dairy cattle and other food animals is prohibited.

Allison Vander Plaats is a postdoctoral associate at Iowa State University Veterinary Field Services, where she is working towards a food animal specialty residency and graduate degree. A California native, she attended Cal Poly San Luis Obispo for her undergraduate work, then went to Cornell University College of Veterinary Medicine for her DVM with a production animal focus. After graduation, she moved back to the Central Valley to join a six-doctor primarily dairy practice for a few years, before then moving to a teaching and staff vet position at a community college. Her professional interests include antibiotic stewardship, veterinary education, and ruminant medicine.

Producers, dairy consultants, and industry representatives are encouraged to attend the free webinar from 12 noon to 1 p.m. on Dec. 19 by registering at least one hour prior to the webinar at https://go.iastate.edu/ASPIRINWEBINAR.

Source : iastate.edu

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.